Scientific Advisory Board
Professor David Grainger
Professor David W. Grainger is the George S. and Dolores Doré Eccles Presidential Endowed Chair in Pharmaceutics and Pharmaceutical Chemistry, Chair of the Department of Pharmaceutics and Pharmaceutical Chemistry, and Distinguished Professor of Pharmaceutics and Bioengineering at the University of Utah.
Prof. Grainger has over 25 years of experience with various aspects of developing “materials in medicine”. His research expertise is focused on improving implanted medical device performance, drug delivery of new therapeutic proteins, nucleic acids and live vaccines, nanomaterials interactions with human tissues, low-infection biomaterials, and innovating diagnostic devices based on DNA and protein biomarker capture. Additionally, he is an expert in application of surface analytical methods to biomedical interfaces. He has published over 150 full research papers and 21 book chapters at the interface of materials innovation in medicine and biotechnology, and novel surface chemistry.
He is Chair and standing member of Emerging Bioanalytical Technologies scientific review group (SRG) at NIH, past standing member on the NIH’s Surgery and Bioengineering SRG, and over of 20 other NIH and NSF review panels and international research foundations groups. Prof. Grainger has helped to found 3 biomedical technology companies, sits on the Scientific Advisory boards for 4 biomedical companies, and actively consults internationally with industries in applications of materials in biotechnologies and medicine.